Presenter: Ethan Russo, MD

Original Date: July 9, 2016

Beyond the psychoactive tetrahydrocannabinol (THC), in recent years, the pharmacologically versatile and non-intoxicating phytocannabinoid, cannabidiol (CBD), has come into focus for its benefits on epilepsy, anxiety, psychosis and as an anti-inflammatory analgesic with no significant drug-abuse liability. Several other phytocannabinoids with interesting pharmacology are illustrated. Similarly, the cannabis terpenoids are potent modulatory and synergistic components of cannabis that contribute to analgesia, mood modulation and attenuate side effects of THC. These are highlighted in context along with the promising cannabis flavonoids and root alkaloids.

1.0 Pharmacology CEUs approved by OBNM